Liver stage antigen 3 Plasmodium falciparum peptides specifically interacting with HepG2 cells

Journal of Molecular Medicine

Volumn 82, Issue 9, 2004, Pages 600-611

  García, Javier E ^a   Curtidor, Hernando ^a   López, Ramses ^a   Rodríguez, Luis ^a   Vera, Ricardo ^a   Valbuena, John ^a   Rosas, Jaiver ^a   Ocampo, Marisol ^a   Puentes, Alvaro ^a   Forero, Martha ^a   Patarroyo, Manuel A ^a   Patarroyo, Manuel Elkin ^a  

^a UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

High activity binding peptides; Liver stage antigen 3; P. falciparum

Indexed keywords

LIVER ANTIGEN; LIVER STAGE ANTIGEN 3; PEPTIDE; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; ANTIGEN SPECIFICITY; ANTIGENICITY; ARTICLE; CELL STRAIN HEPG2; CROSS REACTION; HUMAN; HUMAN CELL; IMMUNOGENICITY; MEMBRANE BINDING; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; ANTIGEN-ANTIBODY REACTIONS; ANTIGENS, PROTOZOAN; BINDING SITES; CELL LINE; CELL MEMBRANE; CROSS REACTIONS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GOATS; HEPATOCYTES; HOST-PARASITE RELATIONS; HUMANS; IMMUNOBLOTTING; MALARIA VACCINES; MALARIA, FALCIPARUM; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PLASMODIUM FALCIPARUM; PROTEIN BINDING;

EID: 4744358781     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00109-004-0573-9     Document Type: Article

References (29)

1. Phillips RS (2001) Current status of malaria and potential for control. Clin Microbiol Rev 14:208-226
2. Daubersies P, Thomas AW, Millet P, Brahimi K, Langermans JAM, Ollomo B, BenMohamed L, Slierendregt B, Eling W, Van Belkum A, Dubreuil G, Meis JF, Guérin-Marchand C, Cayphas S, Cohen J, Gras-Masse H, Druilhe P (2000) Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver stage antigen 3. Nat Med 6:1258-1263
3. Fidock DA, Bottius E, Brahimi K, Moelans II, Aikawa M, Konings RN, Certa U, Olafsson P, Kaidoh T, Asavanich A, Guerin-Marchand C, Druilhe P (1994) Cloning and characterization of a novel Plasmodium falciparum sporozoite surface antigen, STARP. Mol Biochem Parasitol 64:219-232
4. Hollingdale MR, Aikawa M, Atkinson CT, Ballou WR, Chen GX, Li J, Meis JF, Sina B, Wright C, Zhu JD (1990) Non-Cs pre-erythrocytic protection-inducing antigens. Immunol Lett 25:71-76
5. Hollingdale MR, McCormick CJ, Heal KG, Tailor-Robinson AW, Reeve P, Boykins R, Kazura JW (1998) Biology of malarial liver stages: implications for vaccine design. Ann Trop Med Parasitol 92:411-417
6. Aidoo M, Lalvani A, Gilbert SC, Hu JT, Daubersies P, Hurt N, Whittle HC, Druihle P, Hill AV (2000) Cytotoxic T-lymphocyte epitopes for HLA-B53 and other HLA types in the malaria vaccine candidate liver-stage antigen 3. Infect Immun 68:227-232
7. BenMohamed L, Gras-Masse H, Tartar A, Daubersies P, Brahimi K, Bossus M, Thomas A, Druilhe P (1997) Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees. Eur J Immunol 27:1242-1253
8. Perlaza BL, Arevalo-Herrera M, Brahimi K, Quintero G, Palomino JC, Gras-Masse H, Tartar A, Druilhe P, Herrera S (1998) Immunogenicity of four Plasmodium falciparum preerythrocytic antigens in Aotus lemurinus monkeys. Infect Immun 66:3423-3428
9. Sauzet JP, Perlaza BL, Brahimi K, Daubersies P, Druilhe P (2001) DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge. Infect Immun 69:1202-1206
10. Brahimi K, Badell E, Sauzet JP, BenMohamed L, Daubersies P, Guerin-Marchand C, Snounou G, Druilhe P (2001) Human antibodies against Plasmodium falciparum liver-stage antigen 3 cross-react with Plasmodium yoelii preerythrocytic-stage epitopes and inhibit sporozoite invasion in vitro and in vivo. Infect Immun 69:3845-3852
11. Aden D, Fogel A, Plotkin S, Damjanov I, Knowles B (1979) Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature 282:615-616
12. Bchini R, Capel F, Dauguet C, Dubanchet S, Petit AM (1990) In vitro infection of human hepatoma (HepG2) cell with hepatitis B virus. J Virol 64:3025-3032
13. Merrifield RB. Solid phase peptide synthesis (1963) The synthesis of a tetrapeptide. J Am Chem Soc 85:2149-2154
14. Yamamura HY, Enna SJ, Kuhar M (1978) Neurotransmitter receptor binding. Raven, New York
15. Urquiza M, Rodriguez L, Suarez J, Guzman F, Ocampo M, Curtidor H, Segura C, Trujillo E, Patarroyo ME (1996) Identification of peptides from the Plasmodium falciparum MSP-1 protein able to bind to red blood cells. Parasite Immunol 18:515-526
16. García J, Puentes A, Suarez J, Lopéz R, Vera R, Rodriguez LE, Ocampo M, Curtidor H, Forero M, Guzman F, Urquiza M, Patarroyo ME (2002) Regions of HCV E1 and E2 proteins of hepatitis C virus that binding specifically to HepG2 cells. J Hepatol 36:254-262
17. Neurath AR, Kent SBH, Strick N, Parker K (1986) Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 46:429-436
18. García JE, Puentes A, López R, Vera R, Suárez J, Rodríguez LE, Curtidor H, Ocampo M, Tovar D, Forero M, Bermúdez A, Cortés J, Urquiza M, Patarroyo ME (2003) Peptides of the liver stage antigen-1 (LSA-1) of Plasmodium falciparum bind to human hepatocytes. Peptides 24:647-657
19. Hubbard AL, Wall DA, Ma A (1983) Isolation of rat hepatocyte plasma membranes. J Cell Biol 96:217-229
20. Patarroyo ME, Amador R, Clavijo, P (1988) A synthetic vaccine protects humans against challenge with asexual blood stages of malaria. Nature 332:158-161
21. Barnes DA, Wollish W, Nelson RG, Leech JH, Petersen C (1995) Plasmodium falciparum: D260, an intra erythrocytic parasite protein, is a member of the glutamic acid dipeptide-repeat family of proteins. Exp Parasitol 81:79-89
22. Vera Bravo R, Marin V, Garcia J, Urquiza M, Torres E, Trujillo M, Rosas J, Patarroyo ME (2000) Amino terminal peptides of the ring infected erythrocyte surface antigen of Plasmodium falciparum bind specifically to erythrocytes. Vaccine 18:1289-1293
23. Kyhse-Andersen J (1998) Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose. J Biochem Biophys Methods 10:203-209
24. Lambros C, Vanderberg JP (1979) Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 65:418-420
25. Súarez JE, Urquiza M, Puentes A, García JE, Ocampo M, López R, Rodríguez LE, Vera R, Cubillos M, Torres MH, Patarroyo ME (2001) Plasmodium falciparum: Circumsporozoite (CSP) protein peptides specifically bind to HepG2. Vaccine 19:4487-4495
26. López R, García J, Puentes A, Curtidor H, Ocampo M, Vera R, Rodriguez LE, Suarez J, Urquiza M, Rodriguez AL, Reyes CA, Granados CG, Patarroyo, ME (2003) Identification of specific Hep G2 cell binding regions in Plasmodium falciparum sporozoite-threonine-asparagine-rich protein (STARP). Vaccine 21:2404-2411
27. Lopez R, Curtidor H, Urquiza M, Garcia J, Puentes A, Suarez J, Ocampo M, Vera R, Rodriguez LE, Castillo F, Cifuentes G, Patarroyo ME (2001) Plasmodium falciparum: binding studies of peptide derived from the sporozoite surface protein 2 to Hep G2 cells. J Pept Res 58:285-292
28. Benmohamed L, Thomas A, Bossus M, Brahimi K, Wubben J, Gras-Masse H, Druilhe P (2000) High immunogenicity in chimpanzees of peptides and lipopeptides derived from four new Plasmodium falciparum pre-erythrocytic molecules. Vaccine 18:2843-2855
29. Hebert A, Sauzet JP, Lebastard M, Ungeheuer MN, Ave P, Huerre M, Druilhe P (2003) Analysis of intra-hepatic peptide-specific cell recruitment in mice immunised with Plasmodium falciparum antigens. J Immunol Methods 275-:123-132